Prostate Cancer Management: Current Challenges, Emerging Therapies, and Men's Health Implications
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 47
Special Issue Editors
Interests: outcomes research; quality of life management; machine learning/artificial intelligence; survival modeling; regression analysis
Special Issue Information
Dear Colleagues,
Prostate cancer is known both for its indolent progression and long natural history. The course of this disease presents significant challenges regarding prognostication, long-term risk assessment, and survivorship. For publication in this Special Issue, we invite submissions covering a wide range of topics within the management of prostate cancer. These include but are not limited to
- Current challenges in prostate cancer diagnosis and screening;
- The role of biomarkers in diagnosis and prognosis and the importance of early detection;
- Risk stratification and prognostication;
- The potential of emerging therapies to improve the outcome of treatment and reduce side effects;
- Management of treatment-related side effects and/or men’s health implications for prostate cancer survivors;
- Prostate cancer survivorship.
Dr. Linda My Huynh
Dr. Michael J. Baine
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer diagnosis
- prostate cancer prognostication
- cancer survivorship
- side effects
- men’s health
